Sevoflurane may not be a complete sigh of relief in COVID-19.

Kaura, Vikas; Hopkins, Philip M

Kaura, Vikas; Hopkins, Philip M.

Kaura V; Academic Unit of Anaesthesia, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. Electronic address: vkaura@doctors.org.uk.
Hopkins PM; Academic Unit of Anaesthesia, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.

Br J Anaesth ; 125(6): e487-e488, 2020 12.

Article in English | MEDLINE | ID: covidwho-764292

Subject(s)

Anesthetics, Inhalation; Coronavirus Infections/therapy; Critical Care/methods; Hypnotics and Sedatives; Malignant Hyperthermia/etiology; Pneumonia, Viral/therapy; Sevoflurane; COVID-19; Genetic Predisposition to Disease; Humans; Malignant Hyperthermia/genetics; Pandemics

Keywords

COVID-19; ICU; malignant hyperthermia; sedation; sevoflurane; volatile anaesthetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Anesthetics, Inhalation / Critical Care / Sevoflurane / Hypnotics and Sedatives / Malignant Hyperthermia Limits: Humans Language: English Journal: Br J Anaesth Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google